Procalcitonin expands chemistry menu

Beckman Coulter Diagnostics has entered a partnership with Diazyme Laboratories that allows customers access to a procalcitonin (PCT) assay, an important marker for the detection and management of bacterial infections and sepsis. The high-quality, fully automated PCT assay is available for use with Beckman Coulter AU analysers (models 480, 680 and 5800).

Sepsis begins outside the hospital setting in nearly 80% of patients. A Centers for Disease Control and Prevention evaluation found seven in 10 patients with sepsis had recently used healthcare services or had chronic diseases requiring frequent medical care. “Fast diagnosis and treatment is critical for patients with sepsis,” said Dr Mike Samoszuk (Beckman Coulter Diagnostics). “Adding PCT to our chemistry menu offers a tool for detecting and managing bacterial infections and sepsis, which should inform the course and prognosis of the disease and facilitate therapeutic decisions. This addition is a result of our commitment to providing disease state management solutions.”

This assay is the first homogenous PCT assay for use on current Beckman Coulter AU model chemistry analysers, eliminating the need for costly dedicated instrumentation. The assay features a latex-enhanced immunoturbidimetric methodology, which uses multiple monoclonal antibodies for enhanced assay sensitivity and specificity.

www.beckman.com

 

Other news

Upcoming Events

Pathology Horizons 2018 Conference

Lough Erne Resort, Co. Fermanagh, Northern Ireland
September 13-15

Microbe 2018

Hilton Hotel, Sheffield
21-23 September 2018

World Congress of the International Federation of Biomedical Laboratory Science (IFBLS)

Palazza dei Congressi of Firenze
22-26 September 2018

Infection Prevention 2018

Scottish Events Campus, Glasgow
30 September - 2 October 2018

Going Overboard with Microbiology - Women and Children First

Merseyside Maritime Museum, Albert Dock, Liverpool
19 October 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Jun 2018

Biomarker testing in suspected pre-eclampsia

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.